(Q33899630)

29 July 2017

1 reference

title

Indeterminate results in blood donor testing: what you don't know can hurt you. (English)

1 reference

29 July 2017

Dodd RY

1

1 reference

29 July 2017

Stramer SL

series ordinal

2

1 reference

29 July 2017

publication date

1 April 2000

1 reference

Transfusion Medicine Reviews

29 July 2017

published in

1 reference

29 July 2017

volume

14

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

151-160

1 reference

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Human immunodeficiency virus type 1-infected blood donors: behavioral characteristics and reasons for donation. The HIV Blood Donor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Third-generation recombinant immunoblot assay: comparison of reactivities according to hepatitis C virus genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Apparent HIV-1 glycoprotein reactivity on western blot in uninfected blood donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Impact on human immunodeficiency virus type 1 (HIV-1) seroprevalence of the change in HIV-1 western blot criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Detection of human immunodeficiency virus type 1 p24 antigen and plasma RNA: relevance to indeterminate serologic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Indeterminate western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Evaluation of atypical human immunodeficiency virus immunoblot reactivity in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Human immunodeficiency virus infection and indeterminate western blot patterns. Prospective studies in a low prevalence population

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Resolution of infection status of human immunodeficiency virus (HIV)-seroindeterminate donors and high-risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high-preval

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Indeterminate human immunodeficiency virus type 1 western blot may indicate an abortive infection in some low-risk blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Evaluation of HIV type 1 western blot-indeterminate blood donors for the presence of human or bovine retroviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

New anti-human immunodeficiency virus immunoblot assays resolve nonspecific western blot results

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Long-term follow-up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blot.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Identification and characterization of an HIV-2 antibody-positive blood donor in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Simultaneous confirmation and differentiation of human T-lymphotropic virus types I and II infection by modified western blot containing recombinant envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Centers for Disease Control and Prevention and the U.S.P.H.S. Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

The use of a recombinant immunoblot assay in the interpretation of anti- hepatitis C virus reactivity among prospectively followed patients, implicated donors, and random donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Evaluation of indeterminate c22-3 reactivity in volunteer blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

To thy (reactive) donors be true!

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980005-X

7 January 2021

10.1016/S0887-7963(00)80005-X

Identifiers

DOI

1 reference

29 July 2017

1 reference